• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2025 Elections
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    KaloBios Pharmaceuticals has filed for Chapter 11 bankruptcy on Wednesday. The biotech firm had ousted Martin Shkreli as its CEO earlier this month after he was arrested on federal charges of securities fraud. (AP Photo/Craig Ruttle)
    Healthcare

    Arrested drug exec involved in Ponzi-like scheme, feds say

    Robert King -
    December 17, 2015 6:49 pm
    0
    ‘Most hated man’ in healthcare arrested
    Healthcare

    ‘Most hated man’ in healthcare arrested

    Pete Kasperowicz -
    December 17, 2015 12:52 pm
    0
    Turing Pharmaceuticals CEO Martin Shkreli, who announced over the summer that his company would sell anti-malarial treatment Daraprim for 5,000 percent more after gaining its manufacturing license, is invited to testify. (Paul Taggart/Bloomberg)
    Healthcare

    Lawmakers invite controversial drug executives to testify

    Paige Winfield Cunningham -
    December 16, 2015 5:01 am
    0
    The biggest obstacle to congressional approval of TPP appears to be the deal's inadequate protection of intellectual property in
    Healthcare

    TPP trade agreement undercuts biologic patents

    John Graham -
    December 15, 2015 5:01 am
    0
    During the first Senate hearing on high drug prices last week, senators from both parties lauded a solution that would speed approval of certain generic drugs. (AP Photo)
    Healthcare

    Would speeding drug approvals knock down high prices?

    Robert King -
    December 15, 2015 5:01 am
    0
    Healthcare

    Congress may take on high drug prices next year

    Robert King -
    December 10, 2015 12:10 am
    0
    Healthcare

    GOP defends industry at drug price hearing

    Robert King -
    December 9, 2015 9:40 pm
    0
    Local governments need naloxone as an antidote to heroin overdoses, but the price is soaring. (AP Photo/Mel Evans)
    Healthcare

    High drug prices collide with efforts to stop overdoses

    Robert King -
    December 9, 2015 5:01 am
    0
    Healthcare

    Partisan attacks mark Dem drug price hearing

    Robert King -
    December 3, 2015 5:01 am
    0
    In a new analysis, Kaiser and Georgetown University looked at 12 specialty drugs used to treat four diseases: cancer, hepatitis C, multiple sclerosis and rheumatoid arthritis. (AP Photo/Rafiq Maqbool)
    Healthcare

    Seniors face high costs for pricey drugs

    Robert King -
    December 2, 2015 6:20 pm
    0
    1...124125126...151Page 125 of 151
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.